Pexidartinib hydrochloride is the hydrochloride salt form of pexidartinib, a small-molecule receptor tyrosine kinase inhibitor that targets KIT, CSF1R, and FLT3. It is primarily used as an active pharmaceutical ingredient in research and pharmaceutical manufacturing, with antineoplastic activity studied in cancer cell lines.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 2040295-03-0
Indibulin
pharmaceutical raw material
Oseltamivir phosphate
pharmaceutical raw material
Edotreotide
pharmaceutical raw material
Melittin
pharmaceutical raw material
6-Fluoro-N-((5-fluoro-2-methoxypyridin-3-yl)methyl)-5-((5-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl)methyl)pyridin-2-amine
research compound
5-[(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)methyl]-N-[[6-(trifluoromethyl)-3-pyridinyl]methyl]pyridin-2-amine;hydrochloride
CJLUYLRKLUYCEK-UHFFFAOYSA-N
C1=CC(=NC=C1CC2=CNC3=C2C=C(C=N3)Cl)NCC4=CN=C(C=C4)C(F)(F)F.Cl